Sign in

CIK 0001084267 · Non-accelerated filer<br>Smaller reporting company

Mobiquity Technologies, Inc.

Sign in to watch
Tickers
MOBQ MOBQW
Exchange
OTC
Industry
Services-Advertising
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
113427886
Phone
516-256-7766
Business address
35 TORRINGTON LANE, SHOREHAM, NY, 11786
Former names
ACE MARKETING & PROMOTIONS INC

Securities

  • MOBQ Common stock OTC
  • MOBQW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-08 Zurkow Peter L. Director Grant or award · Common Stock Options +25,000 25,000
2021-12-08 Wright Michael A. Director Grant or award · Common Stock Options +25,000 25,000
2021-12-08 Julia Dean L. CEO Grant or award · Common Stock Options +250,000 337,500
2021-12-08 McDonnell Sean CFO Grant or award · Common Stock Options +25,000 28,000
2021-12-08 Iacovone Anthony Director Grant or award · Common Stock Options +25,000 25,000
2021-12-08 Salkind Gene Director Grant or award · Common Stock Options +35,000 1,422,500
2021-09-30 Salkind Gene Director Option exercise +375,000 1,116,021
2021-09-30 Salkind Gene Director Option exercise · Preferred Stock −1,500 1,012,500
2021-09-30 Salkind Gene Director Option exercise · Common Stock Purchase Warrants +375,000 1,387,500
2021-04-01 Salkind Gene Director Grant or award · Notes +150,000 1,684,375
2020-09-08 Salkind Gene Director Grant or award +15,000,000 $0.01 $150K 296,318,355
2020-07-21 Salkind Gene Director Grant or award +15,000,000 $0.01 $150K 281,318,355
2019-09-13 Salkind Gene Director Purchase +35,000,000 $0.01 $336K 126,318,355
2019-09-13 Salkind Gene Director Purchase +127,500,000 $0.02 $2.4M 253,818,355
2019-09-13 Salkind Gene Director Purchase +12,500,000 $0.04 $500K 266,318,355
2019-09-13 Salkind Gene Director Grant or award · Notes +2,300,000 341,502,500
2019-09-13 Salkind Gene Director Purchase +35,000,000 $0.01 $336K 126,318,355
2019-09-13 Salkind Gene Director Purchase +127,500,000 $0.02 $2.4M 253,818,355
2019-09-13 Salkind Gene Director Purchase +12,500,000 $0.04 $500K 266,318,355
2019-09-13 Salkind Gene Director Grant or award · Notes +2,300,000 341,502,500

Page 4 of 9 · 170 trades